Abeona Therapeutics Inc. SEC filings ABEO

Abeona Therapeutics Inc. has 1,000 filings in SEC EDGAR's recent list, going back to Oct 21, 2008. Its latest annual report, Form ARS, was filed on Apr 27, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 15, 2026 (regulation fd disclosure). The company's fiscal year ends on December 31.

Abeona Therapeutics Inc. SEC filings
Form Description Filed Period
SCHEDULE 13D Ownership over 5% (active) Oct 23, 2026 —
4 Insider transaction Sep 29, 2026 Sep 29, 2026
4 Insider transaction Sep 29, 2026 Sep 29, 2026
4 Insider transaction Sep 29, 2026 Sep 29, 2026
4 Insider transaction Sep 29, 2026 Sep 29, 2026
144 Notice of proposed sale Sep 29, 2026 —
144 Notice of proposed sale Sep 29, 2026 —
144 Notice of proposed sale Sep 29, 2026 —
144 Notice of proposed sale Sep 29, 2026 —
8-K Current report
Regulation FD disclosure
Sep 15, 2026 Sep 15, 2026
4 Insider transaction Sep 1, 2026 Sep 1, 2026
144 Notice of proposed sale Sep 1, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2026 —
10-Q Quarterly report Aug 13, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 13, 2026 Aug 13, 2026
4 Insider transaction Jul 22, 2026 Jul 21, 2026
424B3 Prospectus Jul 10, 2026 —
4 Insider transaction Jul 9, 2026 Jul 9, 2026
4 Insider transaction Jul 9, 2026 Jul 9, 2026
4 Insider transaction Jul 9, 2026 Jul 9, 2026
4 Insider transaction Jul 9, 2026 Jul 9, 2026
144 Notice of proposed sale Jul 9, 2026 —
144 Notice of proposed sale Jul 9, 2026 —
144 Notice of proposed sale Jul 9, 2026 —
144 Notice of proposed sale Jul 9, 2026 —
144 Notice of proposed sale Jul 6, 2026 —
4 Insider transaction Jul 2, 2026 Jun 30, 2026
S-8 Employee stock plan registration Jun 26, 2026 —
4 Insider transaction Jun 17, 2026 Jun 16, 2026
4 Insider transaction Jun 15, 2026 Jun 15, 2026
144 Notice of proposed sale Jun 15, 2026 —
8-K Current report
Shareholder vote results
Jun 12, 2026 Jun 12, 2026
8-K Current report
Officer or director change
Jun 12, 2026 Jun 11, 2026
8-K Current report
Regulation FD disclosure
Jun 10, 2026 Jun 10, 2026
4 Insider transaction Jun 9, 2026 Jun 8, 2026
4 Insider transaction Jun 9, 2026 Jun 8, 2026
4 Insider transaction Jun 9, 2026 Jun 8, 2026
4 Insider transaction Jun 9, 2026 Jun 8, 2026
144 Notice of proposed sale Jun 9, 2026 —
144 Notice of proposed sale Jun 8, 2026 —
144 Notice of proposed sale Jun 8, 2026 —
144 Notice of proposed sale Jun 8, 2026 —
144 Notice of proposed sale Jun 8, 2026 —
8-K Current report
Other events
Jun 4, 2026 Jun 3, 2026
4 Insider transaction May 26, 2026 May 26, 2026
4 Insider transaction May 22, 2026 May 22, 2026
144 Notice of proposed sale May 22, 2026 —
4 Insider transaction May 15, 2026 May 15, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2026 —
144 Notice of proposed sale May 15, 2026 —
10-Q Quarterly report May 13, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 13, 2026 May 13, 2026
4 Insider transaction May 11, 2026 May 11, 2026
144 Notice of proposed sale May 11, 2026 —
DEFA14A Additional proxy material May 4, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Apr 28, 2026 —
ARS Annual report to shareholders Apr 27, 2026 Dec 31, 2025
DEF 14A Proxy statement Apr 27, 2026 Apr 27, 2026
PRE 14A Preliminary proxy statement Apr 17, 2026 Apr 17, 2026
4 Insider transaction Apr 7, 2026 Apr 1, 2026
3 Initial insider ownership Apr 7, 2026 Apr 1, 2026
8-K Current report
Officer or director change, Regulation FD disclosure
Apr 7, 2026 Apr 1, 2026
SCHEDULE 13G Ownership over 5% (passive) Apr 6, 2026 —
4 Insider transaction Mar 31, 2026 Mar 31, 2026
144 Notice of proposed sale Mar 31, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Mar 27, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Mar 26, 2026 —
8-K Current report
Bylaw or fiscal year change
Mar 20, 2026 Mar 16, 2026
10-K Annual report Mar 17, 2026 Dec 31, 2025
8-K Current report
Results of operations
Mar 17, 2026 Mar 17, 2026
144 Notice of proposed sale Mar 16, 2026 —
4 Insider transaction Mar 16, 2026 Mar 16, 2026
8-K Current report
Other events
Mar 9, 2026 Mar 9, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 12, 2026 —
144 Notice of proposed sale Feb 9, 2026 —
4 Insider transaction Feb 4, 2026 Feb 2, 2026
4 Insider transaction Feb 2, 2026 Feb 2, 2026
4 Insider transaction Feb 2, 2026 Feb 2, 2026
144 Notice of proposed sale Feb 2, 2026 —
144 Notice of proposed sale Feb 2, 2026 —
144 Notice of proposed sale Feb 2, 2026 —
144 Notice of proposed sale Feb 2, 2026 —
4 Insider transaction Feb 2, 2026 Feb 2, 2026
4 Insider transaction Feb 2, 2026 Feb 2, 2026
4 Insider transaction Jan 27, 2026 Jan 26, 2026
4 Insider transaction Jan 27, 2026 Jan 26, 2026
4 Insider transaction Jan 27, 2026 Jan 26, 2026
4 Insider transaction Jan 27, 2026 Jan 26, 2026
4 Insider transaction Jan 27, 2026 Jan 26, 2026
4 Insider transaction Jan 27, 2026 Jan 26, 2026
4 Insider transaction Jan 27, 2026 Jan 26, 2026
4 Insider transaction Jan 27, 2026 Jan 26, 2026
4 Insider transaction Jan 26, 2026 Jan 20, 2026
3 Initial insider ownership Jan 26, 2026 Jan 1, 2026
4 Insider transaction Jan 22, 2026 Jan 22, 2026
4 Insider transaction Jan 22, 2026 Jan 22, 2026
4 Insider transaction Jan 22, 2026 Jan 22, 2026
144 Notice of proposed sale Jan 22, 2026 —
144 Notice of proposed sale Jan 22, 2026 —
144 Notice of proposed sale Jan 22, 2026 —
144 Notice of proposed sale Jan 22, 2026 —
4 Insider transaction Jan 21, 2026 Jan 21, 2026
144 Notice of proposed sale Jan 21, 2026 —
4 Insider transaction Jan 20, 2026 Jan 20, 2026
4 Insider transaction Jan 20, 2026 Jan 20, 2026
4 Insider transaction Jan 20, 2026 Jan 20, 2026
4 Insider transaction Dec 29, 2025 Dec 29, 2025
144 Notice of proposed sale Dec 29, 2025 —
4 Insider transaction Nov 14, 2025 Nov 13, 2025
144 Notice of proposed sale Nov 13, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 13, 2025 —
10-Q Quarterly report Nov 12, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 12, 2025 Nov 12, 2025
SCHEDULE 13G Ownership over 5% (passive) Oct 30, 2025 —
4 Insider transaction Oct 16, 2025 Oct 16, 2025
144 Notice of proposed sale Oct 16, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Oct 6, 2025 —
SCHEDULE 13G Ownership over 5% (passive) Oct 6, 2025 —
4 Insider transaction Oct 1, 2025 Sep 29, 2025
4 Insider transaction Oct 1, 2025 Sep 29, 2025
4 Insider transaction Oct 1, 2025 Sep 29, 2025
SCHEDULE 13G Ownership over 5% (passive) Sep 30, 2025 —
144 Notice of proposed sale Sep 29, 2025 —
144 Notice of proposed sale Sep 29, 2025 —
144 Notice of proposed sale Sep 29, 2025 —
4 Insider transaction Sep 22, 2025 Sep 22, 2025
144 Notice of proposed sale Sep 22, 2025 —
4 Insider transaction Aug 15, 2025 Aug 14, 2025
4 Insider transaction Aug 15, 2025 Aug 15, 2025
144 Notice of proposed sale Aug 15, 2025 —
10-Q Quarterly report Aug 14, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 14, 2025 Aug 14, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 13, 2025 —
4 Insider transaction Jul 22, 2025 Jul 22, 2025
144 Notice of proposed sale Jul 22, 2025 —
8-K Current report
Material agreement, New debt
Jul 18, 2025 Jul 18, 2025
SCHEDULE 13G Ownership over 5% (passive) Jul 17, 2025 —
4 Insider transaction Jul 10, 2025 Jul 9, 2025
4 Insider transaction Jul 10, 2025 Jul 9, 2025
4 Insider transaction Jul 10, 2025 Jul 9, 2025
4 Insider transaction Jul 10, 2025 Jul 8, 2025
4 Insider transaction Jul 10, 2025 Jul 9, 2025
4 Insider transaction Jul 10, 2025 Jul 9, 2025
4 Insider transaction Jul 10, 2025 Jul 9, 2025
144 Notice of proposed sale Jul 9, 2025 —
144 Notice of proposed sale Jul 9, 2025 —
144 Notice of proposed sale Jul 9, 2025 —
144 Notice of proposed sale Jul 9, 2025 —
144 Notice of proposed sale Jul 9, 2025 —
144 Notice of proposed sale Jul 9, 2025 —
144 Notice of proposed sale Jul 8, 2025 —
8-K Current report
Acquisition or sale of assets, Results of operations, Other events
Jul 2, 2025 Jun 27, 2025
4 Insider transaction Jun 9, 2025 Jun 5, 2025
4 Insider transaction Jun 6, 2025 Jun 6, 2025
4 Insider transaction Jun 6, 2025 Jun 6, 2025
4 Insider transaction Jun 6, 2025 Jun 6, 2025
144 Notice of proposed sale Jun 6, 2025 —
144 Notice of proposed sale Jun 6, 2025 —
144 Notice of proposed sale Jun 6, 2025 —
4 Insider transaction Jun 3, 2025 Jun 1, 2025
4 Insider transaction May 27, 2025 May 27, 2025
144 Notice of proposed sale May 27, 2025 —
8-K Current report
Shareholder vote results
May 19, 2025 May 19, 2025
4 Insider transaction May 16, 2025 May 16, 2025
144 Notice of proposed sale May 16, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2025 —
10-Q Quarterly report May 15, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 15, 2025 May 15, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) May 12, 2025 —
8-K Current report
Material agreement, Other events
May 12, 2025 May 9, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) May 1, 2025 —
8-K Current report
Regulation FD disclosure
Apr 29, 2025 Apr 29, 2025
8-K Current report
Other events
Apr 29, 2025 Apr 29, 2025
DEF 14A Proxy statement Apr 9, 2025 Dec 31, 2024
4 Insider transaction Mar 31, 2025 Mar 31, 2025
144 Notice of proposed sale Mar 31, 2025 —
8-K Current report
Results of operations
Mar 20, 2025 Mar 20, 2025
10-K Annual report Mar 20, 2025 Dec 31, 2024
4 Insider transaction Mar 17, 2025 Mar 14, 2025
4 Insider transaction Mar 4, 2025 Mar 3, 2025
4 Insider transaction Feb 3, 2025 Jan 31, 2025
4 Insider transaction Feb 3, 2025 Jan 31, 2025
4 Insider transaction Feb 3, 2025 Jan 31, 2025
4 Insider transaction Feb 3, 2025 Jan 31, 2025
4 Insider transaction Feb 3, 2025 Jan 31, 2025
4 Insider transaction Feb 3, 2025 Jan 31, 2025
4 Insider transaction Feb 3, 2025 Jan 31, 2025
4 Insider transaction Feb 3, 2025 Jan 31, 2025
4 Insider transaction Jan 31, 2025 Jan 29, 2025
144 Notice of proposed sale Jan 29, 2025 —
4 Insider transaction Jan 23, 2025 Jan 21, 2025
4 Insider transaction Jan 23, 2025 Jan 21, 2025
4 Insider transaction Jan 23, 2025 Jan 21, 2025
4 Insider transaction Jan 21, 2025 Jan 21, 2025
144 Notice of proposed sale Jan 21, 2025 —
S-8 Employee stock plan registration Jan 6, 2025 —
8-K Current report
Officer or director change, Shareholder vote results
Dec 20, 2024 Dec 20, 2024
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
ABEO (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Cleveland, OH
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
318306
Former names
PLASMATECH BIOPHARMACEUTICALS INC (until Jun 4, 2015); ACCESS PHARMACEUTICALS INC (until Aug 14, 2014); CHEMEX PHARMACEUTICALS INC (until Feb 5, 1996)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.